<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Conversational no-code and multi-agentic disease module identification and drug repurposing prediction with ChatDRex - Health AI Hub</title>
    <meta name="description" content="ChatDRex is a novel conversational, multi-agent AI system designed to democratize network-based drug repurposing prediction by providing natural language access">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Conversational no-code and multi-agentic disease module identification and drug repurposing prediction with ChatDRex</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.21438v1" target="_blank">2511.21438v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-26
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Simon S√ºwer, Kester Bagemihl, Sylvie Baier, Lucia Dicunta, Markus List, Jan Baumbach, Andreas Maier, Fernando M. Delgado-Chaves
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.AI, cs.MA
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.21438v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.21438v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">ChatDRex is a novel conversational, multi-agent AI system designed to democratize network-based drug repurposing prediction by providing natural language access to complex bioinformatics analyses. It leverages the integrated NeDRex knowledge graph and specialized agents, enabling physicians and researchers without computer science expertise to identify disease modules and propose drug candidates. This system aims to accelerate the discovery of novel therapies and advance personalized medicine through efficient in silico predictions.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This innovation is crucial for accelerating drug discovery by offering a time-efficient and cost-effective alternative to traditional drug development through repurposing. It empowers clinical experts to directly generate hypotheses and explore novel therapeutic strategies, thereby advancing personalized medicine and translational research.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>ChatDRex is a conversational, multi-agent AI system that uses natural language processing and knowledge graphs to facilitate complex bioinformatic analyses for disease module identification and drug repurposing prediction. It aims to make advanced computational tools accessible to physicians and clinical researchers, accelerating the discovery of novel therapies and advancing personalized medicine.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses critical challenges in in silico drug repurposing, including fragmented tools, heterogeneous data landscapes, and the need for effective collaboration across diverse specializations.</li>
                    
                    <li>Introduces ChatDRex as a conversation-based, multi-agent system specifically engineered for network-based drug repurposing prediction.</li>
                    
                    <li>Built upon the extensive integrated systems medicine knowledge graph, NeDRex, providing access to a rich biomedical data foundation.</li>
                    
                    <li>Features specialized bioinformatics agents for network analysis, drug repurposing algorithm execution, functional coherence evaluation (for in silico validation), literature mining, and scientific discussion of results.</li>
                    
                    <li>Employs a flexible multi-agent design that intelligently routes queries, retrieves data, executes algorithms, and visualizes results.</li>
                    
                    <li>Incorporates a dedicated reasoning module to maintain user involvement, provide transparency, and detect potential AI hallucinations, enhancing reliability.</li>
                    
                    <li>Democratizes access to complex bioinformatics, enabling medical professionals and researchers without computer science expertise to control sophisticated analyses using natural language.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>ChatDRex employs a conversational multi-agent AI architecture integrated with the NeDRex systems medicine knowledge graph. It utilizes natural language processing to interpret user queries, routing them to specialized bioinformatics agents. These agents execute tasks such as network analysis, drug repurposing algorithms, functional coherence evaluation, and literature mining. The system also includes a reasoning module for user interaction and hallucination detection.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The paper presents ChatDRex as a functional and robust conversational, multi-agent system capable of facilitating complex bioinformatic analyses for network-based drug repurposing prediction. It demonstrates that natural language access to extensive biomedical knowledge and integrated specialized agents can effectively bridge the gap between clinical experts and advanced computational tools, enabling hypothesis generation and candidate identification with enhanced transparency via its reasoning module.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>ChatDRex has the potential to significantly accelerate the discovery of novel therapies by streamlining the drug repurposing process, making it faster and more cost-effective. By democratizing access to advanced bioinformatics, it empowers physicians and researchers to directly explore therapeutic opportunities and generate testable hypotheses, ultimately advancing personalized medicine and expediting the translation of research findings into clinical applications.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly stated for ChatDRex itself in the abstract; however, the paper highlights that the system is designed to overcome existing limitations in the field of in silico drug repurposing, such as fragmented tools, heterogeneous data, and the necessity for highly specialized users.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly stated in the abstract.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Precision medicine</span>
                    
                    <span class="tag">Translational research</span>
                    
                    <span class="tag">Drug discovery</span>
                    
                    <span class="tag">Systems medicine</span>
                    
                    <span class="tag">Clinical research</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug repurposing</span>
                    
                    <span class="tag tag-keyword">Multi-agent systems</span>
                    
                    <span class="tag tag-keyword">Natural language processing</span>
                    
                    <span class="tag tag-keyword">Bioinformatics</span>
                    
                    <span class="tag tag-keyword">Knowledge graph</span>
                    
                    <span class="tag tag-keyword">Network analysis</span>
                    
                    <span class="tag tag-keyword">Artificial intelligence</span>
                    
                    <span class="tag tag-keyword">Personalized medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Repurposing approved drugs offers a time-efficient and cost-effective alternative to traditional drug development. However, in silico prediction of repurposing candidates is challenging and requires the effective collaboration of specialists in various fields, including pharmacology, medicine, biology, and bioinformatics. Fragmented, specialized algorithms and tools often address only narrow aspects of the overall problem, and heterogeneous, unstructured data landscapes require specialized users to be involved. Hence, these data services do not integrate smoothly across workflows. With ChatDRex, we present a conversation-based, multi-agent system that facilitates the execution of complex bioinformatic analyses aiming for network-based drug repurposing prediction. It builds on the integrated systems medicine knowledge graph NeDRex. ChatDRex provides natural language access to its extensive biomedical KG and integrates bioinformatics agents for network analysis and drug repurposing, complemented by agents for functional coherence evaluation for in silico validation, as well as agents for literature mining and for discussing the obtained results in a scientific context. Its flexible multi-agent design assigns specific tasks to specialized agents, including query routing, data retrieval, algorithm execution, and result visualization. A dedicated reasoning module keeps the user in the loop and allows for hallucination detection. By enabling physicians and researchers without computer science expertise to control complex analyses in natural language, ChatDRex democratizes access to bioinformatics as an important resource for drug repurposing. It enables clinical experts to generate hypotheses and explore drug repurposing opportunities, ultimately accelerating the discovery of novel therapies and advancing personalized medicine and translational research.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>